Literature DB >> 21232847

A rearranged EP300 gene in the human B-cell lymphoma cell line RC-K8 encodes a disabled transcriptional co-activator that contributes to cell growth and oncogenicity.

Michael R Garbati1, Ryan C Thompson, Leila Haery, Thomas D Gilmore.   

Abstract

Human diffuse large B-cell lymphoma cell line RC-K8 has an altered EP300 locus that encodes a C-terminally truncated histone acetyltransferase (HAT) protein (p300ΔC). We now show that p300ΔC contains 1047N-terminal amino acids of p300 fused to 25 amino acids encoded by sequences from chromosome 6. Over-expressed p300ΔC localized to nuclear subdomains and interacted with transcription factor REL. p300ΔC did not function as a co-activator for REL-directed transactivation, and blocked the ability of wild-type p300 to enhance transcriptional activation by REL. Knock down of p300ΔC in RC-K8 cells reduced their growth in both liquid culture and soft agar. Truncations of p300 were not found in eight other B-lymphoma cell lines. These results suggest that p300ΔC contributes to the oncogenic state of RC-K8 cells by acting as a defective co-activator.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21232847      PMCID: PMC3042717          DOI: 10.1016/j.canlet.2010.12.018

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  45 in total

Review 1.  Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel.

Authors:  T D Gilmore
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

2.  Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation.

Authors:  I Kitabayashi; Y Aikawa; A Yokoyama; F Hosoda; M Nagai; N Kakazu; T Abe; M Ohki
Journal:  Leukemia       Date:  2001-01       Impact factor: 11.528

Review 3.  CBP/p300 in cell growth, transformation, and development.

Authors:  R H Goodman; S Smolik
Journal:  Genes Dev       Date:  2000-07-01       Impact factor: 11.361

Review 4.  p300/CBP/p53 interaction and regulation of the p53 response.

Authors:  S R Grossman
Journal:  Eur J Biochem       Date:  2001-05

5.  Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells.

Authors:  F Emmerich; M Meiser; M Hummel; G Demel; H D Foss; F Jundt; S Mathas; D Krappmann; C Scheidereit; H Stein; B Dörken
Journal:  Blood       Date:  1999-11-01       Impact factor: 22.113

6.  Mutations truncating the EP300 acetylase in human cancers.

Authors:  S A Gayther; S J Batley; L Linger; A Bannister; K Thorpe; S F Chin; Y Daigo; P Russell; A Wilson; H M Sowter; J D Delhanty; B A Ponder; T Kouzarides; C Caldas
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

7.  Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter.

Authors:  L Wang; S R Grossman; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

8.  p300 acts as a transcriptional coactivator for mammalian Notch-1.

Authors:  F Oswald; B Täuber; T Dobner; S Bourteele; U Kostezka; G Adler; S Liptay; R M Schmid
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

9.  Histone acetyltransferase p300 is a coactivator for transcription factor REL and is C-terminally truncated in the human diffuse large B-cell lymphoma cell line RC-K8.

Authors:  Michael R Garbati; Gökçen Alço; Thomas D Gilmore
Journal:  Cancer Lett       Date:  2009-11-30       Impact factor: 8.679

10.  CREB-binding protein (CBP)/p300 and RNA polymerase II colocalize in transcriptionally active domains in the nucleus.

Authors:  A von Mikecz; S Zhang; M Montminy; E M Tan; P Hemmerich
Journal:  J Cell Biol       Date:  2000-07-10       Impact factor: 10.539

View more
  9 in total

1.  c-Rel regulates Ezh2 expression in activated lymphocytes and malignant lymphoid cells.

Authors:  Wen Hao Neo; Jun Feng Lim; Raelene Grumont; Steve Gerondakis; I-Hsin Su
Journal:  J Biol Chem       Date:  2014-09-29       Impact factor: 5.157

Review 2.  Epigenetics and B-cell lymphoma.

Authors:  Rita Shaknovich; Ari Melnick
Journal:  Curr Opin Hematol       Date:  2011-07       Impact factor: 3.284

3.  The c-Rel Transcription Factor in Development and Disease.

Authors:  Thomas D Gilmore; Steve Gerondakis
Journal:  Genes Cancer       Date:  2011-07

4.  Sea anemone model has a single Toll-like receptor that can function in pathogen detection, NF-κB signal transduction, and development.

Authors:  Joseph J Brennan; Jonathan L Messerschmidt; Leah M Williams; Bryan J Matthews; Marinaliz Reynoso; Thomas D Gilmore
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-06       Impact factor: 11.205

5.  Evidence for an oncogenic modifier role for mutant histone acetyltransferases in diffuse large B-cell lymphoma.

Authors:  Leila Haery; Sultan Mussakhan; David J Waxman; Thomas D Gilmore
Journal:  Leuk Lymphoma       Date:  2016-03-22

Review 6.  Histone acetyltransferases and histone deacetylases in B- and T-cell development, physiology and malignancy.

Authors:  Leila Haery; Ryan C Thompson; Thomas D Gilmore
Journal:  Genes Cancer       Date:  2015-05

7.  Genome-wide CRISPR screens reveal synthetic lethal interaction between CREBBP and EP300 in diffuse large B-cell lymphoma.

Authors:  Man Nie; Likun Du; Weicheng Ren; Julia Joung; Xiaofei Ye; Xi Shi; Sibel Ciftci; Dongbing Liu; Kui Wu; Feng Zhang; Qiang Pan-Hammarström
Journal:  Cell Death Dis       Date:  2021-04-28       Impact factor: 8.469

8.  The sensitivity of diffuse large B-cell lymphoma cell lines to histone deacetylase inhibitor-induced apoptosis is modulated by BCL-2 family protein activity.

Authors:  Ryan C Thompson; Iosif Vardinogiannis; Thomas D Gilmore
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

9.  Histone acetyltransferase-deficient p300 mutants in diffuse large B cell lymphoma have altered transcriptional regulatory activities and are required for optimal cell growth.

Authors:  Leila Haery; Julián G Lugo-Picó; Ryan A Henry; Andrew J Andrews; Thomas D Gilmore
Journal:  Mol Cancer       Date:  2014-02-15       Impact factor: 27.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.